Action MITRA MITHRA PHARMACEUTICALS S.A.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Mithra Pharmaceuticals S.A.

Actions

MITRA

BE0974283153

Marché Fermé - Euronext Bruxelles
Autres places de cotation
 17:35:26 26/04/2024 		Varia. 5j. Varia. 1 janv.
0,216 EUR -1,82% Graphique intraday de Mithra Pharmaceuticals S.A. -.--% -82,78%
29/04 Mithra Pharmaceuticals reporte la publication de son rapport annuel 2023 CI
08/03 Mithra Pharmaceuticals SA publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Mithra postpones its annual general meeting
GL
Mithra announces grant of two additional U.S. patents for NEXTSTELLIS
AQ
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
AQ
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
GL
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023
GL
Mithra secures court protection measures to advance monetization process
GL
Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses
AQ
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study
PU
Mithra reports full year 2023 financial results
GL
Mithra announces changes to its executive management
AQ
Mithra announces changes to its executive management
GL
Mithra announces changes to its executive management
AQ
Mithra initiates monetization process, receives bridge loan from existing lenders
GL
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase
AQ
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
GL
Mithra sells shares in Mayne Pharma
GL
Mithra Announces its 2024 Financial Calendar
AQ
Mithra updates on cash position
GL
Mithra updates on cash position
AQ
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MITRA
  4. Actualités Mithra Pharmaceuticals S.A.
  5. Communiqués
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT